English
2021 High quality (R)-(+)-4-Methoxy-α-methylbenzylamine - (S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 Afatinib Amprenavir Fosamprenavir Intermediate – Ruifu Featured Image
  • 2021 High quality (R)-(+)-4-Methoxy-α-methylbenzylamine - (S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 Afatinib Amprenavir Fosamprenavir Intermediate – Ruifu

2021 High quality (R)-(+)-4-Methoxy-α-methylbenzylamine - (S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 Afatinib Amprenavir Fosamprenavir Intermediate – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

, , ,
2021 High quality (R)-(+)-4-Methoxy-α-methylbenzylamine - (S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 Afatinib Amprenavir Fosamprenavir Intermediate – Ruifu Detail:

Manufacturer Supply; Hot Product; High Purity and Competitive Price
(S)-3-Hydroxytetrahydrofuran CAS: 86087-23-2  
Afatinib (formerly BIBW 2992, CAS 439081-18-2) Main Intermediate
Amprenavir (CAS 161814-49-9) and Fosamprenavir (CAS 226700-79-4) Intermediate

Chemical Name (S)-3-Hydroxytetrahydrofuran
Synonyms (S)-Tetrahydrofuran-3-ol; (S)-(+)-Tetrahydro-3-furanol
CAS Number 86087-23-2
CAT Number RF-CC101
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C4H8O2
Molecular Weight 88.11
Boiling Point 80℃
Density 1.103 g/mL at 25℃ (lit.)
Refractive Index n20/D 1.45(lit.)
Water Solubility Soluble
Brand Ruifu Chemical
Item Specifications
Appearance Colerless transparent to light yellwow liquid
Purity / Analysis Method ≥99.0% (GC)
Identification Retention time of the sample should match with the retention time of reference standard
Specific Rotation [α]D20 +17.5° ± 2.5° (C=2 in MeOH)
Optical Purity e.e ≥99.0% (GC)
Moisture (K.F) ≤0.50%
(R)-(-)-3-Hydroxytetrahydrofuran  ≤0.15%
Any Other Single Impurity ≤0.4%
Total impurities ≤1.0%
Test Standard Enterprise Standard
Usage Afatinib, Amprenavir and Amprenavir Phosphate Intermediate 

(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 ROS

86087-23-2 ROS

Package: Bottle, Fluoride Barrels, 25kg/Barrel, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

121

Afatinib (CAS 439081-18-2) is a potent, covalent/irreversible, and orally bioavailable dual (EGFR/ErbB) receptor tyrosine kinase (RTK) inhibitor with anticancer activity.  
Afatinib (CAS 439081-18-2) is a prescription medicine that can be taken orally for the treatment of non-small cell lung cancer (NSCLC) with atypical Epidermal Growth Factor Receptor (EFGR) agents. Afatinib is also prescribed for the treatment of NSCLC with the potential or radiating to other body tissues other than the lungs (metastatic cancer) as detected through an FDA approved examination. Afatinib (CAS 439081-18-2) is a 4-anilinoquinazoline tyrosine kinase suppressor that is available as a dimaleate salt (brand name: Giltrif). The drug is the first FDA-endorsed oncology product by Boehringer Ingelheim.

Amprenavir (CAS 161814-49-9) is a HIV protease inhibitor used to treat HIV infection. Amprenavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.09 μM.
Fosamprenavir (CAS  226700-79-4) (Amprenavir phosphate;GW 433908) is a phosphate ester prodrug of the antiretroviral protease inhibitor Amprenavi.

Product detail pictures:

2021 High quality (R)-(+)-4-Methoxy-α-methylbenzylamine - (S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 Afatinib Amprenavir Fosamprenavir Intermediate – Ruifu detail pictures

Related Product Guide:
2021 High quality (R)-(+)-4-Methoxy-α-methylbenzylamine - (S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 Afatinib Amprenavir Fosamprenavir Intermediate – Ruifu , The product will supply to all over the world, such as: , , ,

    • 5 Stars By from -

    5 Stars By from -
    Write your message here and send it to us